ORIGINAL RESEARCH
Accepted on 28 May 2025
Targeting CD16A on NK Cells and GPC3 in Hepatocellular Carcinoma: Development and Functional Validation of a Therapeutic Bispecific Antibody
doi 10.3389/fimmu.2025.1599764
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Immunology and Therapeutic Innovations in Hepatocellular Carcinoma: Exploring Immune Evasion and Beyond
Immunology and Therapeutic Innovations in Hepatocellular Carcinoma: Exploring Immune Evasion and Beyond
80
Total downloads
1,186
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 23 May 2025
Lenvatinib versus bevacizumab when combined with PD-1/L1 inhibitor and hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma
doi 10.3389/fimmu.2025.1573098
- 341 views
SYSTEMATIC REVIEW
Published on 21 May 2025
The impact of immune checkpoint inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a meta-analysis
doi 10.3389/fimmu.2025.1573505
- 311 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: